Avacta Group

Unit 706 Avenue E West
Thorp Arch Estate
Wetherby
LS23 7GA
United Kingdom

+44 1904 217072

Activities

R and D | Biotechnology

Related Content

Avacta expands South Korean partnership to include COVID-19 neutralising therapy

Avacta, Daewoong and AffyXell to work on proteins for a range of targets

Moderna uses option for exclusive product licence

Avacta and LG Chem Life Sciences agree multitarget Affimer therapeutics development alliance

Avacta announces successful outcome of gene delivery collaboration

Two US biotech companies licence Affimer reagents for research use

Key biotherapeutics patent to be granted in China

Avacta announces CAR-T cell therapy research collaboration with major US cancer centre

Avacta expands into new facilities in Cambridge and Wetherby

Avacta to collaborate with Glythera to develop antibody-drug conjugates

Jobs and People

Avacta Group appoints new Non-Executive Director

Avacta Group establishes US business development team

World-leading cancer stem cell expert joins Avacta Scientific advisory board

Avacta hires Philippe Cotrel as Chief Commercial Officer

Similar Companies